SEC Form 4 · accession 0001213900-18-011178
Icagen, Inc. · ICGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Tyson
Director · 10% Owner
Period of report
Aug 13, 2018
Accepted (ET)
Aug 15, 2018 · 3:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001518520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $3.50 | Aug 13, 2018 | A | 45,000 | A | Aug 13, 2018 | Aug 13, 2023 | Common Stock | 45,000 | 45,000 | I |
Explanation of responses
- F1The warrants (the "Warrants") were issued to the reporting person by Icagen, Inc. (the "Company") in a private placement offering of units (the "Units" and each a "Unit") with each Unit sold at a price of $10,000 per Unit and each Unit consisting of (i) a note in the principal amount of $10,000, and (ii) a five year warrant to acquire 1,500 shares of the Company's common stock, par value, $0.001 per share ("Common Stock"), at an exercise price of $3.50 per share. Each Warrant is exercisable for one share of Common Stock.